Secondary Logo

Journal Logo

You can read the full text of this article if you:

Ovid Member Institutional Access
Original Articles

Safety and feasibility of estrogen receptor-β targeted phytoSERM formulation for menopausal symptoms: phase 1b/2a randomized clinical trial

Schneider, Lon S. MD, MS1; Hernandez, Gerson MD, MPH2; Zhao, Liqin PhD3; Franke, Adrian A. PhD4; Chen, Yu-Ling MS1; Pawluczyk, Sonia MD1; Mack, Wendy J. PhD1; Brinton, Roberta D. PhD2

Author Information
doi: 10.1097/GME.0000000000001325
  • Buy
  • SDC


© 2019 by The North American Menopause Society